We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
-9.63%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$357M
AUM Growth
-$138M
Cap. Flow
-$93.3M
Cap. Flow %
-26.14%
Top 10 Hldgs %
47.67%
Holding
86
New
5
Increased
13
Reduced
45
Closed
18

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$10.7M
2
VEEV icon
Veeva Systems
VEEV
+$9.9M
3
ALL icon
Allstate
ALL
+$8.81M
4
AMZN icon
Amazon
AMZN
+$8.72M
5
ABBV icon
AbbVie
ABBV
+$8.6M

Sector Composition

Rank Sector Weight
1 Technology 33.62%
2 Healthcare 24.24%
3 Financials 14.33%
4 Communication Services 7.36%
5 Consumer Discretionary 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EW icon
26
Edwards Lifesciences
EW
$47.6B
$5.83M 1.63%
92,700
-169,200
-65% -$12.2M
A icon
27
Agilent Technologies
A
$39.1B
$4.35M 1.22%
+60,700
New +$4.88M
AMT icon
28
American Tower
AMT
$77.7B
$4.22M 1.18%
19,370
-50
-0.3% -$11.6K
DHR icon
29
Danaher
DHR
$135B
$3.87M 1.09%
31,573
-225
-0.7% -$30.3K
VZ icon
30
Verizon
VZ
$194B
$3.73M 1.04%
69,365
-4,400
-6% -$252K
TMO icon
31
Thermo Fisher Scientific
TMO
$211B
$3.64M 1.02%
12,839
+100
+0.8% +$31.5K
LULU icon
32
lululemon athletica
LULU
$13B
$3.37M 0.95%
17,800
-36,050
-67% -$8.07M
VAR
33
DELISTED
Varian Medical Systems, Inc.
VAR
$3.03M 0.85%
+29,515
New +$3.9M
MASI
34
DELISTED
Masimo
MASI
$2.6M 0.73%
14,650
-550
-4% -$94.3K
ILMN icon
35
Illumina
ILMN
$29.4B
$2.53M 0.71%
9,512
-565
-6% -$158K
SYK icon
36
Stryker
SYK
$127B
$2.15M 0.6%
12,900
-500
-4% -$97.7K
UNH icon
37
UnitedHealth
UNH
$382B
$1.93M 0.54%
7,750
-650
-8% -$179K
CHD icon
38
Church & Dwight Co
CHD
$23.1B
$1.87M 0.53%
29,200
-200
-0.7% -$14.2K
GIS icon
39
General Mills
GIS
$19.2B
$1.57M 0.44%
29,850
-900
-3% -$47.5K
PG icon
40
Procter & Gamble
PG
$343B
$1.31M 0.37%
11,928
-82,950
-87% -$9.96M
AWK icon
41
American Water Works
AWK
$26.3B
$1.06M 0.3%
8,850
-37,000
-81% -$4.77M
NBIX icon
42
Neurocrine Biosciences
NBIX
$17.7B
$1.02M 0.29%
11,750
-300
-2% -$29.4K
MAS icon
43
Masco
MAS
$16B
$875K 0.25%
25,300
-1,100
-4% -$48K
ATO icon
44
Atmos Energy
ATO
$29.9B
$854K 0.24%
8,610
-7,790
-48% -$857K
BFAM icon
45
Bright Horizons
BFAM
$3.99B
$846K 0.24%
8,300
-600
-7% -$88.2K
WASH icon
46
Washington Trust Bancorp
WASH
$732M
$806K 0.23%
22,041
+14,777
+203% +$668K
HSIC icon
47
Henry Schein
HSIC
$9.74B
$790K 0.22%
15,630
-9,280
-37% -$589K
STE icon
48
Steris
STE
$20.9B
$763K 0.21%
5,450
-100
-2% -$15K
GILD icon
49
Gilead Sciences
GILD
$161B
$689K 0.19%
9,215
-5,075
-36% -$351K
IART icon
50
Integra LifeSciences
IART
$1.54B
$643K 0.18%
14,398
-100
-0.7% -$5.25K

Similar funds

De Burlo Group's Q1 2020 Portfolio in Review

As of Q1 2020, De Burlo Group held 86 positions worth $357M, down 28% from $495M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

De Burlo Group withdrew a net $93.3M in Q1 2020, closing 18 positions and reducing 45 holdings. Its most notable exit was PNC Financial Services, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

Against the trend, De Burlo Group opened a new position in Veeva Systems worth $10.6M.

  • De Burlo Group's largest Q1 2020 buy was Veeva Systems: 67,550 shares worth $10.6M.
  • De Burlo Group added most to Salesforce in Q1 2020, an estimated $10.7M increase.
  • De Burlo Group's biggest Q1 2020 reduction was Edwards Lifesciences, cutting an estimated $12.2M.
  • De Burlo Group fully exited PNC Financial Services in Q1 2020, selling an estimated $15.9M.
  • De Burlo Group's ten largest holdings make up 48% of its $357M portfolio in Q1 2020.
  • De Burlo Group opened 5 new positions and closed 18 in Q1 2020.
  • De Burlo Group's portfolio value fell 28% quarter-over-quarter to $357M.

Based on De Burlo Group's 13F filing for Q1 2020, filed 7 May 2020.